FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285387572> ?p ?o ?g. }

• W4285387572 abstract "Background Zero-time Exercise (ZTEx), a simple strength- and stamina-enhancing physical activity (PA) requiring no extra equipment, can potentially increase PA and fitness. This pilot trial examined the feasibility and potential effectiveness of a smartphone ZTEx intervention to promote PA and fitness in patients with coronary heart disease (CHD). Methods A parallel-group assessor-blinded pilot randomized controlled trial was conducted on Chinese patients with stable coronary heart disease (CHD) in three cardiology clinics. The experimental group received a 15-min brief individual face-to-face session and a 12-week ZTEx instant messaging with 28 picture e-messages and a smartphone ZTEx application (ZTExApp). The control group received the same duration of individual session and number and format of e-messages, but the content was healthy eating and breathing exercise. The feasibility was assessed based on: attrition rate, usage, response rate and perception of the intervention. The outcome evaluation included primary outcome (PA), fitness, exercise self-efficacy and intention, perceived happiness and health, and quality of life. A linear mixed model was used with intention-to-treat analysis adjusting for sex, age and baseline values. A semi-structured interview was conducted to collect feedback from the experiment group. Results One hundred thirty-nine patients (mean age 59.8 ± 6.6; 71.2% male) were randomized to the experimental group ( n = 70) or control group ( n = 69), and 80% (56/70) and 82% (57/69) of patients completed the 12-week follow-up assessment, respectively. The attrition rate was 18.7%. The experimental group reported that ZTEx was feasible to integrate PA into their daily life and appreciated the picture e-messages, and 95% of them sent feedback to us, but only 19.6% (13/70) of the participants entered their PA information into the e-diary of the ZTExApp. The experimental group had a significantly greater increase in time spent walking [mean difference (95% CI): 155.3 (10.1, 300.4), P = 0.04, Cohen's d = 0.34] than the control group. Conclusions This pilot study showed using a brief ZTEx face-to-face session with picture e-messages empowered patients with CHD to integrate PA into daily life. Future definitive trials with a longer follow-up and a more user-friendly ZTExApp interface are necessary to determine the effectiveness of the smartphone ZTEx intervention in enhancing PA and related outcomes. Trial Registration The research protocol was registered at the Hong Kong University Clinical Trials Registry (HKUCTR) on 22 Jul 2016 (Study identifier: HKUCTR-2165) and was also retrospectively registered at the National Institutes of Health (identifier number: NCT03464331) on 14 March 2018." @default.
• W4285387572 created "2022-07-14" @default.
• W4285387572 creator A5003012752 @default.
• W4285387572 creator A5011566264 @default.
• W4285387572 creator A5015636044 @default.
• W4285387572 creator A5016064452 @default.
• W4285387572 creator A5023742847 @default.
• W4285387572 creator A5024148230 @default.
• W4285387572 creator A5045314629 @default.
• W4285387572 creator A5053754557 @default.
• W4285387572 creator A5056608120 @default.
• W4285387572 creator A5065370118 @default.
• W4285387572 creator A5068857996 @default.
• W4285387572 date "2022-07-14" @default.
• W4285387572 modified "2023-10-01" @default.
• W4285387572 title "Feasibility and Potential Effectiveness of a Smartphone Zero-Time Exercise Intervention for Promoting Physical Activity and Fitness in Patients With Coronary Heart Disease: A Pilot Randomized Controlled Trial" @default.
• W4285387572 cites W1517168335 @default.
• W4285387572 cites W1854618833 @default.
• W4285387572 cites W1963814214 @default.
• W4285387572 cites W1980110190 @default.
• W4285387572 cites W1986962569 @default.
• W4285387572 cites W1991881145 @default.
• W4285387572 cites W2026150720 @default.
• W4285387572 cites W2045234305 @default.
• W4285387572 cites W2054103341 @default.
• W4285387572 cites W2077948002 @default.
• W4285387572 cites W2099233982 @default.
• W4285387572 cites W2125362811 @default.
• W4285387572 cites W2128142081 @default.
• W4285387572 cites W2153278078 @default.
• W4285387572 cites W2156225582 @default.
• W4285387572 cites W2159294672 @default.
• W4285387572 cites W2178720062 @default.
• W4285387572 cites W2397984037 @default.
• W4285387572 cites W2486769222 @default.
• W4285387572 cites W2511876639 @default.
• W4285387572 cites W2545082340 @default.
• W4285387572 cites W2725683706 @default.
• W4285387572 cites W2810160776 @default.
• W4285387572 cites W2888578824 @default.
• W4285387572 cites W2889109358 @default.
• W4285387572 cites W2897948142 @default.
• W4285387572 cites W2900726805 @default.
• W4285387572 cites W2918912686 @default.
• W4285387572 cites W2935978195 @default.
• W4285387572 cites W2970530873 @default.
• W4285387572 cites W2984890298 @default.
• W4285387572 cites W3006905406 @default.
• W4285387572 cites W3025267430 @default.
• W4285387572 cites W3083411422 @default.
• W4285387572 cites W3092590712 @default.
• W4285387572 cites W3136353089 @default.
• W4285387572 cites W3175033838 @default.
• W4285387572 cites W3195231442 @default.
• W4285387572 cites W3200387216 @default.
• W4285387572 cites W4200232572 @default.
• W4285387572 cites W4200294839 @default.
• W4285387572 cites W63956684 @default.
• W4285387572 cites W6599314 @default.
• W4285387572 doi "https://doi.org/10.3389/fpubh.2022.865712" @default.
• W4285387572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35910893" @default.
• W4285387572 hasPublicationYear "2022" @default.
• W4285387572 type Work @default.
• W4285387572 citedByCount "3" @default.
• W4285387572 countsByYear W42853875722023 @default.
• W4285387572 crossrefType "journal-article" @default.
• W4285387572 hasAuthorship W4285387572A5003012752 @default.
• W4285387572 hasAuthorship W4285387572A5011566264 @default.
• W4285387572 hasAuthorship W4285387572A5015636044 @default.
• W4285387572 hasAuthorship W4285387572A5016064452 @default.
• W4285387572 hasAuthorship W4285387572A5023742847 @default.
• W4285387572 hasAuthorship W4285387572A5024148230 @default.
• W4285387572 hasAuthorship W4285387572A5045314629 @default.
• W4285387572 hasAuthorship W4285387572A5053754557 @default.
• W4285387572 hasAuthorship W4285387572A5056608120 @default.
• W4285387572 hasAuthorship W4285387572A5065370118 @default.
• W4285387572 hasAuthorship W4285387572A5068857996 @default.
• W4285387572 hasBestOaLocation W42853875721 @default.
• W4285387572 hasConcept C118552586 @default.
• W4285387572 hasConcept C126322002 @default.
• W4285387572 hasConcept C159110408 @default.
• W4285387572 hasConcept C168563851 @default.
• W4285387572 hasConcept C1862650 @default.
• W4285387572 hasConcept C199343813 @default.
• W4285387572 hasConcept C2777953023 @default.
• W4285387572 hasConcept C2779951463 @default.
• W4285387572 hasConcept C2780553607 @default.
• W4285387572 hasConcept C2780665704 @default.
• W4285387572 hasConcept C71924100 @default.
• W4285387572 hasConcept C84393581 @default.
• W4285387572 hasConceptScore W4285387572C118552586 @default.
• W4285387572 hasConceptScore W4285387572C126322002 @default.
• W4285387572 hasConceptScore W4285387572C159110408 @default.
• W4285387572 hasConceptScore W4285387572C168563851 @default.
• W4285387572 hasConceptScore W4285387572C1862650 @default.
• W4285387572 hasConceptScore W4285387572C199343813 @default.
• W4285387572 hasConceptScore W4285387572C2777953023 @default.
• W4285387572 hasConceptScore W4285387572C2779951463 @default.
• W4285387572 hasConceptScore W4285387572C2780553607 @default.
• W4285387572 hasConceptScore W4285387572C2780665704 @default.

• next